Funding: 
No funding has been declared.
borderline tuberculoid leprosy
multibacillary leprosy
cell-mediated immunity
lepromatous leprosy
tuberculoid leprosy
multi-drug therapy
reversal reaction
silent neuritis
Type 2
Type 1
MDT
ROM
CMI
RR
BI
TT
BT
BL
LL
BB
PB
MB